Oral treatment may not be far off for head and neck cancer patients 

Features
Published
A highly promising approach to treating HPV-driven head and neck cancer is on the way, and it could be in the shape of a simple oral medication. This is according to new breakthrough research led by Griffith University, which has conducted trials showing that the drug, Alisertib, tested in trials to treat other cancers such as lung and kidney, can also successfully destroy the cancer cells associated with head and neck cancer. Human Papilloma Virus (HPV) […]

Hayfever patients can benefit from probiotics

Features
Published
New research from a pilot study at Griffith has shown that probiotics can improve the quality of life of hayfever patients. As part of a clinical first-of-its-kind development program, the researchers investigated whether a multispecies-probiotic formulation, which has been shown in previous research to reduce eczema in children, could benefit hayfever patents as well. They […]